Skip to content

Comparing the efficacy of Amritadi Guggulu and Vyoshadi Guggulu after Virechana (Therapeutic Purgation) in patients of Medoroga (Dyslipidemia)

Comparative clinical study to evaluate efficacy of Amritadi Guggulu and Vyoshadi Guggulu after Virechana in the management of Medoroga (Dyslipidemia)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039995
Enrollment
80
Registered
2022-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Pratyatma Lakshan of Medoroga Patient fulfilling the Diagnostic Criteria of Dyslipidemia Patients of Age group between 21 to 50 years irrespective of gender, caste, creed and body weight Patients fit for Virechana karma Patient willing and able to give written consent in the study

Exclusion criteria

Exclusion criteria: Patients with poorly controlled Diabetes Mellitus (HbA1c >10%) and Hypertension ( BP > 160 / 100 mm Hg) Pregnant / lactating woman Patients with genetic syndromes, severe cardiovascular disease or any other life threatening condition. History of hypersensitivity to any of the trial drugs or their ingredients. Patients unfit for Virechana karma Patients having systemic illness which will interfere with the course of procedure. Patients who are already enrolled in other study.

Design outcomes

Primary

MeasureTime frame
Improvement in the Signs and Symptoms of Medoroga Change in the haematological parameters of DyslipidemiaTimepoint: Before and After Treatment

Secondary

MeasureTime frame
Improvement in the quality of life as assessed with the help of questionnaires for scaling of Quality Of Life (SF 36) Changes in Body Mass Index, Skin Fold Thickness (Triceps and Abdomen) and Waist- Hip Ratio.Timepoint: 105 Days

Countries

India

Contacts

Public ContactProf Dr Jonah S

All India Institute Of Ayurveda

jonahdr@gmail.com9448262298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026